FDA
approval
· 2017-09-13
FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)
Summary
FDA approved Cumberland Pharmaceuticals' supplemental application for SANCUSO (granisetron). The granisetron product is used to prevent chemotherapy- and surger…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SANCUSO (GRANISETRON)